Digestive System Diseases  >>  toreforant (JNJ-38518168)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
toreforant (JNJ-38518168) / J&J
NCT01863784: A Study to Evaluate the Pharmacokinetics of JNJ-38518168 in Patients With Mild and Moderate Hepatic Impairment Compared With Patients With Normal Hepatic Function

Completed
1
28
US
JNJ-38518168
Janssen Research & Development, LLC
Hepatic Impairment
11/13
11/13

Download Options